The European Union’s landmark Joint Clinical Assessment (JCA) for Ipsen’s orphan-designated drug Ojemda (tovorafenib) has been published, marking a significant…
Read More

The European Union’s landmark Joint Clinical Assessment (JCA) for Ipsen’s orphan-designated drug Ojemda (tovorafenib) has been published, marking a significant…
Read More
In recent years, the pharmaceutical industry has witnessed a dramatic acceleration in the adoption of New Approach Methodologies (NAMs) for…
Read More
The rapid acceleration in the adoption of New Approach Methodologies (NAMs) for drug safety testing, often perceived as a sudden…
Read More
The landscape of drug safety testing is undergoing a profound transformation, marked by the rapid ascent of New Approach Methodologies…
Read More
In recent years, the landscape of drug safety testing has undergone a profound transformation, marked by the rapid acceleration of…
Read More
The rapid acceleration of New Approach Methodologies (NAMs) in drug safety testing has, for many, appeared to be a sudden…
Read More
The advent of the Joint Clinical Assessment (JCA) process in the European Union, designed to harmonize the clinical evaluation of…
Read More
A groundbreaking study led by researchers from Washington University School of Medicine and Children’s Hospital of Philadelphia has identified a…
Read More
A groundbreaking study conducted by researchers from Washington University School of Medicine and Children’s Hospital of Philadelphia has identified a…
Read More
The National Safety Council (NSC), a leading advocate for workplace safety, has introduced a groundbreaking digital assessment tool designed to…
Read More